Advancing Therapies Propel Paroxysmal Nocturnal Hemoglobinuria Treatment Market Toward Robust Growth by 2034 – Patient Worthy

Advancing Therapies Propel Paroxysmal Nocturnal Hemoglobinuria Treatment Market Toward Robust Growth by 2034 – Patient Worthy

The global market for treating Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare but serious blood disorder, is poised for significant growth through 2034, according to a recent analysis by DelveInsight reported by MENAFIN. This optimistic outlook is fueled by a dynamic clinical development pipeline and rising awareness of the disease, which causes red blood cells to […]